Effects of Psychotropic Drugs on Quantitative EEG among Patients with Schizophrenia-spectrum Disorders
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objective: We examined how psychotropic medications affected quantitative EEG (qEEG) results among patients with a schizophrenia-spectrum disorder. Methods: The drugs were clustered into nine groups depending on their mechanism. We hypothesized that drugs would affect the relative power shown in qEEG results independently and investigated the effect of each drug group on relative power using multiple linear regression analysis and independent samples t-tests. Results: We found that antipsychotics other than clozapine induced an increase in the relative power of alpha activity. Clozapine markedly increased slow waves and decreased alpha activity in the occipital area. The main findings for antidepressants and antiepileptic drugs were the beta increment and lithium increased the power of delta and theta activity. However, we found no evident changes in power due to benzodiazepine. Conclusion: Our results are generally consistent with previous pharmaco-EEG studies, despite some differences. Therefore,the EEG effect in each drug group could be singled out even under the polypharmacy condition, with the possible exception of benzodiazepines. Our results support using a new methodological approach to identify the qEEG effects of various psychotropic drugs in clinical settings.
Abstract
Objective: We examined how psychotropic medications affected quantitative EEG (qEEG) results among patients with a schizophrenia-spectrum disorder. Methods: The drugs were clustered into nine groups depending on their mechanism. We hypothesized that drugs would affect the relative power shown in qEEG results independently and investigated the effect of each drug group on relative power using multiple linear regression analysis and independent samples t-tests. Results: We found that antipsychotics other than clozapine induced an increase in the relative power of alpha activity. Clozapine markedly increased slow waves and decreased alpha activity in the occipital area. The main findings for antidepressants and antiepileptic drugs were the beta increment and lithium increased the power of delta and theta activity. However, we found no evident changes in power due to benzodiazepine. Conclusion: Our results are generally consistent with previous pharmaco-EEG studies, despite some differences. Therefore,the EEG effect in each drug group could be singled out even under the polypharmacy condition, with the possible exception of benzodiazepines. Our results support using a new methodological approach to identify the qEEG effects of various psychotropic drugs in clinical settings.
참고문헌 (27)
- Galderisi S, "Pharmaco-EEG: a history of progress and a missed opportunity", Clin EEG Neurosci, 37, pp.31~35 (2006)
- Nuwer M, "Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society", Neurology, 49, pp.227~292 (1997)
- Itil TM, "Quantitative EEG brain mapping in psychotropic drug development, drug treatment selection, and monitoring", Am J Ther, 2, pp.359~367 (1995)
- Mucci A, "Pharmaco-EEG in psychiatry", Clin EEG Neurosci, 37, pp.81~98 (2006)
- Hughes AM, "Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers", Br J Clin Pharmacol, 48, pp.323~330 (1999)
- Hubl D, "Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine", Psychopharmacology (Berl), 158, pp.281~288 (2001)
- Saletu B, "Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine", Neuropsychobiology, 29, pp.125~135 (1994)
- Cañive JM, "Spontaneous brain magnetic activity in schizophrenia patients treated with aripiprazole", Psychopharmacol Bull, 34, pp.101~105 (1998)
- Galderisi S, "Evidence-based medicine and electrophysiology in schizophrenia", Clin EEG Neurosci, 40, pp.62~77 (2009)
- Knott V, "Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment", Schizophr Res, 50, pp.41~53 (2001)
- Gross A, "Clozapineinduced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study", Pharmacopsychiatry, 37, pp.119~122 (2004)
- Galderisi S, "Multilead quantitative EEG profile of clozapine in resting and vigilance-controlled conditions", Psychiatry Res, 67, pp.113~122 (1996)
- Knott V, "Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome", Pharmacopsychiatry, 33, pp.201~205 (2000)
- Siepmann M, "Effects of sertraline on autonomic and cognitive functions in healthy volunteers", Psychopharmacology (Berl), 168, pp.293~298 (2003)
- Saletu B, "EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs", Clin EEG Neurosci, 37, pp.66~80 (2006)
- Sannita WG, "Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients", Neuropsychobiology, 22, pp.231~235 (1989)
- Clemens B, "Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings", Epilepsy Res, 70, pp.190~199 (2006)
- Salinsky MC, "Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures", Epilepsia, 44, pp.1042~1050 (2003)
- Herrmann WM, "Electroencephalographic and psychoexperimental studies in healthy subjects on lithium medication (author's transl)", Pharmakopsychiatr Neuropsychopharmakol, 13, pp.200~212 (1980)
- Thau K, "Effect of lithium on the EEG of healthy males and females", A probability mapping study. Neuropsychobiology, 20, pp.158~163 (1989)
- Fitton A, "Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia", Drugs, 40, pp.722~747 (1990)
- Small JG, "Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia", Clin Electroencephalogr, 18, pp.124~135 (1997)
- Saletu B, "On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine", J Neural Transm, 67, pp.241~266 (1986)
- Saletu B, "Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA)", Methods Find Exp Clin Pharmacol, 24(Suppl C), pp.97~120 (2002)
- Clemens B, "EEG frequency profiles of idiopathic generalised epilepsy syndromes", Epilepsy Res, 42, pp.105~115 (2000)
- Schulz C, "Lithium-induced EEG changes in patients with affective disorders", Neuropsychobiology, 42(Suppl 1), pp.33~37 (2002)
- Siepmann M, "Effects of caffeine on topographic quantitative EEG", Neuropsychobiology, 45, pp.161~166 (2002)